Health Condition 1: null- ASA I & II
Conditions
Interventions
Intervention1: DEXMEDETOMIDINE(1mcg/kg), FENTANYL(1and2mcg/kg),
PROPOFOL (IN INCREMENTAL/DECREMENTAL DOSE): DEXMEDETOMIDINE(1mcg/kg) or FENTANYL(1AND2mcg/kg)EITHER OF THEM(as per group) WILL BE GIVEN
Sponsors
SAFDARJUNG HOSPITAL
Eligibility
Inclusion criteria
Inclusion criteria: ASA GRADE I&II WEIGHT 35-80KGS OR BMI OF PATIENTS WHO GIVE INFORMED WRITTEN CONSENT PATIENTS FOR ELECTIVE SURGICAL PROCEDURES
Exclusion criteria
Exclusion criteria: PATIENTS WITH HISTORY OF GERD DIFFICULT AIRWAY MALLAMPATTI SCORE >2 PATIENTS WITH CERVICAL SPINE DISEASE MOUTH OPENING OBESE PATIENTS WITH BMI >30KG/M2 PATIENTS WITH CARDIOVASCULAR DISEASE
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MEAN ARTERIAL PRESSURE, HEART RATE, OXYGEN SATURATION, END TIDAL CARBON DIOXIDETimepoint: BASELINE T0, END OF ADJUVANT DRUG INJECTION T1, AFTER PROPOFOL INJECTION T2, 1 AND 3 MIN POST LMA INSERTION T3,T4 | — |
Secondary
| Measure | Time frame |
|---|---|
| BRADYCARDIA HR LESS THAN 30%OF BASELINE FOR MORE THAN 1 MIN. APNOEA, MOVEMENT TO INSERTIONTimepoint: DURING ADJUVANT DRUG INFUSION, AT THE TIME OF LMA INSERTION | — |
Countries
India
Contacts
Public ContactDR RAMA WASON
SAFDARJUNG HOSPITAL
Outcome results
None listed